Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-20

Clinical Trial Update: A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lutropin alfa for effects on embryo quality and implantation rate in advanced reproductive-age infertility; the study was terminated an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Luveris (lutropin alfa)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility, Ovulation Induction | Phase 2 | Status: TERMINATED | Results posted: 2012-11-20